Physiological changes following MIE in NMD

  • Research type

    Research Study

  • Full title

    Respiratory physiological changes following MIE (mechanical insufflation-exsufflation) in neuromuscular disease: Optimisation of pressure delivery

  • IRAS ID

    191122

  • Contact name

    Patrick Murphy

  • Contact email

    patrick.murphy@gstt.nhs.uk

  • Sponsor organisation

    Guy's & St Thomas' Foundation NHS Trust

  • Clinicaltrials.gov Identifier

    NCT02753959

  • Duration of Study in the UK

    0 years, 5 months, 2 days

  • Research summary

    This study aims to compare how the lung fills with air using three methods for clearing secretion(clearing mucus or phlegm from the airways), in order to determine the best way to clear secreations in patients with neuromuscular disease (NMD). \n\nPatients with NMD can suffer from a range of respiratory problems due to respiratory muscle weakness. Cough muscle weakness means secretion clearance from the airways can be problematic, and a source of infection. As a result, these patients are often supported with devices to aid clearance (such as mechanical insufflation-exsufflation, MIE) and reduce the risk of infection. Although evidence supports the use of these devices, the optimal technique or settings on the device are not clear. \n\nThis study will have two cohorts. The first is in NMD patients with evidence of respiratory muscle weakness, who are stable.. The second will include patients with NMD who are admitted to the Lane Fox Unit or Critical Care at St. Thomas’ Hospital, with an acute deterioration in their respiratory function, requiring physiotherapy to aid their secretion clearance. \n\nThe study protocol for both groups of patients will be the same. After being recruited into the study, they will undergo some simple non-invasive baseline measurements. They will then undergo three different methods of secretion clearance. Each method will last one hour, with 30 minutes between each method to allow the patient to rest. Throughout the testing stage, respiratory function will be monitored using non-invasive probes. \n\nEach patient will undergo approximately five hours of testing. The study will start in May 2016 and end in October 2016.\n

  • REC name

    London - City & East Research Ethics Committee

  • REC reference

    16/LO/0966

  • Date of REC Opinion

    30 Jun 2016

  • REC opinion

    Further Information Favourable Opinion